CD36 and metabolic syndrome: The insights gained from our LEC palmitoylation profile, in unstimulated and insulin-treated cells, with or without CD36, provide a foundation for future research aimed at exploring the role of lipid metabolism and insulin signaling in lymphatic vessels during homeostasis and the metabolic syndrome, characterized by altered lipid profile and insulin resistance.